NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

Trikalinos TA, Moorthy D, Chung M, et al. Comparison of Translational Patterns in Two Nutrient-Disease Associations: Nutritional Research Series, Vol. 5. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011 Oct. (Technical Reviews, No. 17.5.)

Cover of Comparison of Translational Patterns in Two Nutrient-Disease Associations

Comparison of Translational Patterns in Two Nutrient-Disease Associations: Nutritional Research Series, Vol. 5.

Show details

References

1.
Esmaillzadeh A, Kimiagar M, Mehrabi Y, et al. Fruit and vegetable intakes, C-reactive protein, and the metabolic syndrome. Am J Clin Nutr. 2006;84:1489–97. [PubMed: 17158434]
2.
Koushik A, Hunter DJ, Spiegelman D, et al. Intake of the major carotenoids and the risk of epithelial ovarian cancer in a pooled analysis of 10 cohort studies. Int J Cancer. 2006;119:2148–54. [PubMed: 16823847]
3.
Lee JE, Giovannucci E, Smith-Warner SA, et al. Intakes of fruits, vegetables, vitamins A, C, and E, and carotenoids and risk of renal cell cancer. Cancer Epidemiol Biomarkers Prev. 2006;15:2445–52. [PubMed: 17164369]
4.
Lin J, Zhang SM, Cook NR, et al. Dietary intakes of fruit, vegetables, and fiber, and risk of colorectal cancer in a prospective cohort of women (United States) Cancer Causes Control. 2005;16:225–33. [PubMed: 15947874]
5.
Shai I, Jiang R, Manson JE, et al. Ethnicity, obesity, and risk of type 2 diabetes in women: a 20-year follow-up study. Diabetes Care. 2006;29:1585–90. [PubMed: 16801583]
6.
Schatzkin A, Lanza E, Corle D, et al. Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med. 2000;342:1149–55. [PubMed: 10770979]
7.
Yusuf S, Dagenais G, Pogue J, et al. Vitamin E supplementation and cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators. N Engl J Med. 2000;342:154–60. [PubMed: 10639540]
8.
The effect of vitamin E beta carotene on the incidence of lung cancer and other cancers in male smokers. The Alpha-Tocopherol, Beta Carotene Cancer Prevention Study Group. N Engl J Med. 1994;330:1029–35. [PubMed: 8127329]
9.
Rapola JM, Virtamo J, Ripatti S, et al. Randomised trial of alpha-tocopherol and beta-carotene supplements on incidence of major coronary events in men with previous myocardial infarction. Lancet. 1997;349:1715–20. [PubMed: 9193380]
10.
Sesso HD, Buring JE, Christen WG, et al. Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA. 2008;300:2123–33. [PMC free article: PMC2586922] [PubMed: 18997197]
11.
Bazzano LA, Reynolds K, Holder KN, et al. Effect of folic acid supplementation on risk of cardiovascular diseases: a meta-analysis of randomized controlled trials. JAMA. 2006;296:2720–2726. [PubMed: 17164458]
12.
Wang C, Chung M, Balk EM, et al. Effects of Omega-3 Fatty Acids on Cardiovascular Disease Evidence Report/Technology Assessment No 94, AHRQ Publication No 04-E009-2. Rockville, MD: Agency for Healthcare Research and Quality; 2004. (Prepared by Tufts-New England Medical Center Evidence-based Practice Center under Contract No 290-02-0022)
13.
Wang C, Harris WS, Chung M, et al. n-3 Fatty acids from fish or fish-oil supplements, but not alpha-linolenic acid, benefit cardiovascular disease outcomes in primary- and secondary-prevention studies: a systematic review. Am J Clin Nutr. 2006;84:5–17. [PubMed: 16825676]
14.
Leon H, Shibata MC, Sivakumaran S, et al. Effect of fish oil on arrhythmias and mortality: systematic review. BMJ. 2008;337:a2931. [PMC free article: PMC2612582] [PubMed: 19106137]
15.
Konig A, Bouzan C, Cohen JT, et al. A quantitative analysis of fish consumption and coronary heart disease mortality. Am J Prev Med. 2005;29:335–46. [PubMed: 16242600]
16.
Ye Z, Song H. Antioxidant vitamins intake and the risk of coronary heart disease: meta-analysis of cohort studies. Eur J Cardiovasc Prev Rehabil. 2008;15:26–34. [PubMed: 18277182]
17.
Mente A, de KL, Shannon HS, et al. A systematic review of the evidence supporting a causal link between dietary factors and coronary heart disease. Arch Intern Med. 2009;169:659–69. [PubMed: 19364995]
18.
Batagelj V. Efficient algorithms for citation network analysis. 2003. (Preprint series). University of Ljubljana, Institute of Mathematics, Physics, and Mechanics, Department of Theoretical Computer Science www​.imfm.si/preprinti/PDF/00897.pdf.
19.
deNooy W, Mrvar A, Batagelj V. Exploratory social network analysis with Pajek. Granovetter M, editor. New York: Cambridge University Press; 2005. (Structural analysis in the social sciences).
20.
Clark J, Holton DA. A first look at graph theory. London: World Scientific; 1991.
21.
Koller D, Friedman N. Probabilistic graphical models - principles and techniques. Cambridge, MA: The MIT Press; 2009.
22.
Alsheikh-Ali AA, Kitsios GD, Balk EM, et al. The vulnerable atherosclerotic plaque: scope of the literature. Ann Intern Med. 2010;153:387–95. [PubMed: 20713770]
23.
Dahabreh I, Terasawa T, Castaldi P, et al. CYP2D6 testing to predict response to tamoxifen in women with breast cancer. Pharmacogenomic PLoS Curr. 2010;2 [PMC free article: PMC2940141] [PubMed: 20877451]
24.
Dahabreh IJ, Terasawa T, Castaldi PJ, et al. Systematic review: Anti-epidermal growth factor receptor treatment effect modification by KRAS mutations in advanced colorectal cancer. Ann Intern Med. 2011;154:37–49. [PubMed: 21200037]
25.
Terasawa T, Dahabreh I, Trikalinos TA. BCR-ABL mutation testing to predict response to tyrosine kinase inhibitors in patients with chronic myeloid leukemia. PLoS Curr. 2010;2 RRN1204. [PMC free article: PMC3001986] [PubMed: 21188137]
26.
Rimm EB, Stampfer MJ, Ascherio A, et al. Vitamin E consumption and the risk of coronary heart disease in men. N Engl J Med. 1993;328:1450–6. [PubMed: 8479464]
27.
Hummon N, Doreian P. Connectivity in a citation network: the development of DNA theory. Social Networks. 1989;11:39–63.
28.
Hummon N, Doreian P. Computational methods for social network analysis. Social Networks. 1990;12:273–88.
29.
Harris JK, Luke DA, Zuckerman RB, Shelton SC. Forty years of secondhand smoke research: the gap between discovery and delivery. Am J Prev Med. 2009;36:538–48. [PubMed: 19372026]
30.
Durrington PN, Bhatnagar D, Mackness MI, et al. An omega-3 polyunsaturated fatty acid concentrate administered for one year decreased triglycerides in simvastatin treated patients with coronary heart disease and persisting hypertriglyceridaemia. Heart. 2001;85:544–8. [PMC free article: PMC1729738] [PubMed: 11303007]
31.
Calò L, Bianconi L, Colivicchi F, et al. N-3 Fatty acids for the prevention of atrial fibrillation after coronary artery bypass surgery: a randomized, controlled trial. J Am Coll Cardiol. 2005;45:1723–28. [PubMed: 15893193]
32.
Marchioli R, Levantesi G, Macchia A, et al. Antiarrhythmic mechanisms of n-3 PUFA and the results of the GISSI-Prevenzione trial. J Membr Biol. 2005;206:117–28. [PubMed: 16456722]
33.
Macchia A, Levantesi G, Franzosi MG, et al. Left ventricular systolic dysfunction, total mortality, and sudden death in patients with myocardial infarction treated with n-3 polyunsaturated fatty acids. Eur J Heart Fail. 2005;7:904–9. [PubMed: 16087142]
34.
Nilsen DW, Albrektsen G, Landmark K, et al. Effects of a high-dose concentrate of n-3 fatty acids or corn oil introduced early after an acute myocardial infarction on serum triacylglycerol and HDL cholesterol. Am J Clin Nutr. 2001;74:50–56. [PubMed: 11451717]
35.
Sacks FM, Stone PH, Gibson CM, Silverman DI, Rosner B, Pasternak RC. Controlled trial of fish oil for regression of human coronary atherosclerosis. HARP Research Group. J Am Coll Cardiol. 1995;25:1492–8. [PubMed: 7759696]
36.
Singh RB, Niaz MA, Sharma JP, et al. Randomized, double-blind, placebo-controlled trial of fish oil and mustard oil in patients with suspected acute myocardial infarction: the Indian experiment of infarct survival--4. Cardiovasc Drugs Ther. 1997;11:485–91. [PubMed: 9310278]
37.
Tavazzi L, Maggioni AP, Marchioli R, et al. Effect of n-3 polyunsaturated fatty acids in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial. Lancet. 2008;372:1223–30. [PubMed: 18757090]
38.
vonSchacky C, Angerer P, Kothny W, et al. The effect of dietary omega-3 fatty acids on coronary atherosclerosis. A randomized, double-blind, placebo-controlled trial. Ann Intern Med. 1999;130:554–62. [PubMed: 10189324]
39.
Johansen O, Seljeflot I, Hostmark AT, et al. The effect of supplementation with omega-3 fatty acids on soluble markers of endothelial function in patients with coronary heart disease. Arterioscler Thromb Vasc Biol. 1999;19:1681–6. [PubMed: 10397685]
40.
Leng GC, Lee AJ, Fowkes FG, et al. Randomized controlled trial of gamma-linolenic acid and eicosapentaenoic acid in peripheral arterial disease. Clin Nutr. 1998;17:265–71. [PubMed: 10205349]
41.
Yokoyama M, Origasa H, Matsuzaki M, et al. Effects of eicosapentaenoic acid on major coronary events in hypercholesterolaemic patients (JELIS): a randomised open-label, blinded endpoint analysis. Lancet. 2007;369:1090–8. [PubMed: 17398308]
42.
Brouwer IA, Zock PL, Camm AJ, et al. Effect of fish oil on ventricular tachyarrhythmia and death in patients with implantable cardioverter defibrillators: the Study on Omega-3 Fatty Acids and Ventricular Arrhythmia (SOFA) randomized trial. JAMA. 2006;295:2613–19. [PubMed: 16772624]
43.
Leaf A, Albert CM, Josephson M, et al. Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake. Circulation. 2005;112:2762–68. [PubMed: 16267249]
44.
Raitt MH, Connor WE, Morris C, et al. Fish oil supplementation and risk of ventricular tachycardia and ventricular fibrillation in patients with implantable defibrillators: a randomized controlled trial. JAMA. 2005;293:2884–91. [PubMed: 15956633]
45.
Yuan JM, Ross RK, Gao YT, et al. Fish and shellfish consumption in relation to death from myocardial infarction among men in Shanghai, China. Am J Epidemiol. 2001;154:809–16. [PubMed: 11682363]
46.
Pietinen P, Ascherio A, Korhonen P, et al. Intake of fatty acids and risk of coronary heart disease in a cohort of Finnish men. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study. Am J Epidemiol. 1997;145:876–87. [PubMed: 9149659]
47.
Nagata C, Takatsuka N, Shimizu H. Soy and fish oil intake and mortality in a Japanese community. Am J Epidemiol. 2002;156:824–31. [PubMed: 12397000]
48.
Kaushik S, Wang JJ, Flood V, et al. Frequency of fish consumption, retinal microvascular signs and vascular mortality. Microcirculation. 2008;15:27–36. [PubMed: 17907016]
49.
Kamphuis MH, Geerlings MI, Tijhuis MA, et al. Depression and cardiovascular mortality: a role for n-3 fatty acids? Am J Clin Nutr. 2006;84:1513–17. [PubMed: 17158437]
50.
Jarvinen R, Knekt P, Rissanen H, et al. Intake of fish and long-chain n-3 fatty acids and the risk of coronary heart mortality in men and women. Br J Nutr. 2006;95:824–29. [PubMed: 16571163]
51.
Iso H, Kobayashi M, Ishihara J, et al. Intake of fish and n3 fatty acids and risk of coronary heart disease among Japanese: the Japan Public Health Center-Based (JPHC) Study Cohort I. Circulation. 2006;113:195–202. [PubMed: 16401768]
52.
Folsom AR, Demissie Z. Fish intake, marine omega-3 fatty acids, and mortality in a cohort of postmenopausal women. Am J Epidemiol. 2004;160:1005–10. [PubMed: 15522857]
53.
Dolecek TA. Epidemiological evidence of relationships between dietary polyunsaturated fatty acids and mortality in the multiple risk factor intervention trial. Proc Soc Exp Biol Med. 1992;200:177–82. [PubMed: 1579579]
54.
Albert CM, Hennekens CH, O'Donnell CJ, et al. Fish consumption and risk of sudden cardiac death. JAMA. 1998;279:23–8. [PubMed: 9424039]
55.
Virtamo J, Rapola JM, Ripatti S, et al. Effect of vitamin E and beta carotene on the incidence of primary nonfatal myocardial infarction and fatal coronary heart disease. Arch Intern Med. 1998;158:668–75. [PubMed: 9521232]
56.
Stephens NG, Parsons A, Schofield PM, et al. Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS) Lancet. 1996;347:781–86. [PubMed: 8622332]
57.
Boaz M, Smetana S, Weinstein T, et al. Secondary prevention with antioxidants of cardiovascular disease in endstage renal disease (SPACE): randomised placebo-controlled trial. Lancet. 2000;356:1213–18. [PubMed: 11072938]
58.
Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico. Lancet. 1999;354:447–55. [PubMed: 10465168]
59.
Sacco M, Pellegrini F, Roncaglioni MC, et al. Primary prevention of cardiovascular events with low-dose aspirin and vitamin E in type 2 diabetic patients: results of the Primary Prevention Project (PPP) trial. Diabetes Care. 2003;26:3264–72. [PubMed: 14633812]
60.
Lonn E, Bosch J, Yusuf S, et al. Effects of long-term vitamin E supplementation on cardiovascular events and cancer: a randomized controlled trial. JAMA. 2005;293:1338–47. [PubMed: 15769967]
61.
Lee IM, Cook NR, Gaziano JM, et al. Vitamin E in the primary prevention of cardiovascular disease and cancer: the Women's Health Study: a randomized controlled trial. JAMA. 2005;294:56–65. [PubMed: 15998891]
62.
Hodis HN, Mack WJ, LaBree L, et al. Alpha-tocopherol supplementation in healthy individuals reduces low-density lipoprotein oxidation but not atherosclerosis: the Vitamin E Atherosclerosis Prevention Study (VEAPS) Circulation. 2002;106:1453–59. [PubMed: 12234947]
63.
deGaetano G. Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project. Lancet. 2001;357:89–95. [PubMed: 11197445]
64.
Cook NR, Albert CM, Gaziano JM, et al. A randomized factorial trial of vitamins C and E and beta carotene in the secondary prevention of cardiovascular events in women: results from the Women's Antioxidant Cardiovascular Study. Arch Intern Med. 2007;167:1610–1618. [PMC free article: PMC2034519] [PubMed: 17698683]
65.
Devaraj S, Tang R, ms-Huet B, et al. Effect of high-dose alpha-tocopherol supplementation on biomarkers of oxidative stress and inflammation and carotid atherosclerosis in patients with coronary artery disease. Am J Clin Nutr. 2007;86:1392–98. [PMC free article: PMC2692902] [PubMed: 17991651]
66.
Milman U, Blum S, Shapira C, et al. Vitamin E supplementation reduces cardiovascular events in a subgroup of middle-aged individuals with both type 2 diabetes mellitus and the haptoglobin 2-2 genotype: a prospective double-blinded clinical trial. Arterioscler Thromb Vasc Biol. 2008;28:341–47. [PubMed: 18032779]
67.
Fraser GE, Shavlik DJ. Risk factors for all-cause and coronary heart disease mortality in the oldest-old. The Adventist Health Study. Arch Intern Med. 1997;157:2249–58. [PubMed: 9343002]
68.
Losonczy KG, Harris TB, Havlik RJ. Vitamin E and vitamin C supplement use and risk of all-cause and coronary heart disease mortality in older persons: the Established Populations for Epidemiologic Studies of the Elderly. Am J Clin Nutr. 1996;64:190–196. [PubMed: 8694019]
69.
Knekt P, Reunanen A, Jarvinen R, et al. Antioxidant vitamin intake and coronary mortality in a longitudinal population study. Am J Epidemiol. 1994;139:1180–9. [PubMed: 8209876]
70.
Kushi LH, Folsom AR, Prineas RJ, et al. Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N Engl J Med. 1996;334:1156–62. [PubMed: 8602181]
71.
Sahyoun NR, Jacques PF, Russell RM. Carotenoids, vitamins C and E, and mortality in an elderly population. Am J Epidemiol. 1996;144:501–11. [PubMed: 8781466]
72.
Pocobelli G, Peters U, Kristal AR, White E. Use of supplements of multivitamins, vitamin C, and vitamin E in relation to mortality. Am J Epidemiol. 2009;170:472–83. [PMC free article: PMC2727181] [PubMed: 19596711]
73.
Buijsse B, Feskens EJ, Kwape L, et al. Both alpha- and beta-carotene, but not tocopherols and vitamin C, are inversely related to 15-year cardiovascular mortality in Dutch elderly men. J Nutr. 2008;138:344–50. [PubMed: 18203902]
74.
Genkinger JM, Platz EA, Hoffman SC, et al. Fruit, vegetable, and antioxidant intake and all-cause, cancer, and cardiovascular disease mortality in a community-dwelling population in Washington County, Maryland. Am J Epidemiol. 2004;160:1223–33. [PubMed: 15583375]
75.
Dietrich M, Jacques PF, Pencina MJ, et al. Vitamin E supplement use and the incidence of cardiovascular disease and all-cause mortality in the Framingham Heart Study: Does the underlying health status play a role? Atherosclerosis. 2009;205:549–53. [PMC free article: PMC2717181] [PubMed: 19195657]
76.
Iso H, Kubota Y. Nutrition and disease in the Japan Collaborative Cohort Study for Evaluation of Cancer (JACC) Asian Pac J Cancer Prev. 2007;8(Suppl):35–80. [PubMed: 18260705]
77.
Todd S, Woodward M, Tunstall-Pedoe H, et al. Dietary antioxidant vitamins and fiber in the etiology of cardiovascular disease and all-causes mortality: results from the Scottish Heart Health Study. Am J Epidemiol. 1999;150:1073–80. [PubMed: 10568622]
78.
Klipstein-Grobusch K, Geleijnse JM, den Breeijen JH, et al. Dietary antioxidants and risk of myocardial infarction in the elderly: the Rotterdam Study. Am J Clin Nutr. 1999;69:261–66. [PubMed: 9989690]
79.
Stampfer MJ, Hennekens CH, Manson JE, et al. Vitamin E consumption and the risk of coronary disease in women. N Engl J Med. 1993;328:1444–49. [PubMed: 8479463]
80.
Kromhout D, Bosschieter EB, de Lezenne CC. The inverse relation between fish consumption and 20-year mortality from coronary heart disease. N Engl J Med. 1985;312:1205–9. [PubMed: 3990713]
81.
Daviglus ML, Stamler J, Orencia AJ, et al. Fish consumption and the 30-year risk of fatal myocardial infarction. N Engl J Med. 1997;336:1046–53. [PubMed: 9091800]
82.
Greenberg SA. How citation distortions create unfounded authority: analysis of a citation network. BMJ. 2009;339:b2680. [PMC free article: PMC2714656] [PubMed: 19622839]
83.
van Gent CM, Luten JB, Bronsgeest-Schoute HC, et al. Effect, on serum lipid levels of omega-3 fatty acids, of ingesting fish-oil concentrate. Lancet. 1979;2:1249–50. [PubMed: 92666]
84.
Mortensen JZ, Schmidt EB, Nielsen AH, et al. The effect of N-6 and N-3 polyunsaturated fatty acids on hemostasis, blood lipids and blood pressure. Thromb Haemost. 1983;50:543–46. [PubMed: 6636033]
85.
Norris PG, Jones CJ, Weston MJ. Effect of dietary supplementation with fish oil on systolic blood pressure in mild essential hypertension. Br Med J (Clin Res Ed) 1986;293:104–5. [PMC free article: PMC1340841] [PubMed: 3089408]
86.
Knapp HR, FitzGerald GA. The antihypertensive effects of fish oil. A controlled study of polyunsaturated fatty acid supplements in essential hypertension. N Engl J Med. 1989;320:1037–43. [PubMed: 2648152]
87.
Simopoulos AP. Omega-3 fatty acids in health and disease and in growth and development. Am J Clin Nutr. 1991;54:438–63. [PubMed: 1908631]
88.
Guallar E, Hennekens CH, Sacks FM, et al. A prospective study of plasma fish oil levels and incidence of myocardial infarction in U.S. male physicians. J Am Coll Cardiol. 1995;25:387–94. [PubMed: 7829792]
89.
Ascherio A, Rimm EB, Stampfer MJ, et al. Dietary intake of marine n-3 fatty acids, fish intake, and the risk of coronary disease among men. N Engl J Med. 1995;332:977–82. [PubMed: 7885425]
90.
de Lorgeril M, Salen P, Martin JL, et al. Mediterranean diet, traditional risk factors, and the rate of cardiovascular complications after myocardial infarction: final report of the Lyon Diet Heart Study. Circulation. 1999;99:779–85. [PubMed: 9989963]
91.
Hu FB, Bronner L, Willett WC, et al. Fish and omega-3 fatty acid intake and risk of coronary heart disease in women. JAMA. 2002;287:1815–21. [PubMed: 11939867]
92.
Mozaffarian D, Lemaitre RN, Kuller LH, et al. Cardiac benefits of fish consumption may depend on the type of fish meal consumed: the Cardiovascular Health Study. Circulation. 2003;107:1372–77. [PubMed: 12642356]
93.
Mozaffarian D, Psaty BM, Rimm EB, et al. Fish intake and risk of incident atrial fibrillation. Circulation. 2004;110:368–73. [PMC free article: PMC1201400] [PubMed: 15262826]
94.
Breslow JL. n-3 fatty acids and cardiovascular disease. Am J Clin Nutr. 2006;83:1477S–82S. [PubMed: 16841857]
95.
Mozaffarian D, Rimm EB. Fish intake, contaminants, and human health: evaluating the risks and the benefits. JAMA. 2006;296:1885–99. [PubMed: 17047219]
96.
Jenkins DJ, Josse AR, Beyene J, et al. Fish-oil supplementation in patients with implantable cardioverter defibrillators: a meta-analysis. CMAJ. 2008;178:157–64. [PMC free article: PMC2174988] [PubMed: 18195289]
97.
Mozaffarian D, Stein PK, Prineas RJ, et al. Dietary fish and omega-3 fatty acid consumption and heart rate variability in US adults. Circulation. 2008;117:1130–7. [PubMed: 18285566]
98.
Stahelin HB, Rosel F, Buess E, et al. Cancer, vitamins, and plasma lipids: prospective Basel study. J Natl Cancer Inst. 1984;73:1463–68. [PubMed: 6595456]
99.
Gey KF, Brubacher GB, Stahelin HB. Plasma levels of antioxidant vitamins in relation to ischemic heart disease and cancer. Am J Clin Nutr. 1987;45:1368–77. [PubMed: 3495167]
100.
Hodis HN, Mack WJ, LaBree L, et al. Serial coronary angiographic evidence that antioxidant vitamin intake reduces progression of coronary artery atherosclerosis. JAMA. 1995 June 21;273(23):1849–54. [PubMed: 7776501]
101.
Ogunyankin K. Vitamin E and coronary heart disease. Lancet. 1996;347:1689. [PubMed: 8642973]
102.
Leppala JM, Virtamo J, Fogelholm R, et al. Controlled trial of alpha-tocopherol and beta-carotene supplements on stroke incidence and mortality in male smokers 11. Arterioscler Thromb Vasc Biol. 2000;20:230–5. [PubMed: 10634823]
103.
Muntwyler J, Hennekens CH, Manson JE, et al. Vitamin supplement use in a low-risk population of US male physicians and subsequent cardiovascular mortality. Arch Intern Med. 2002;162:1472–6. [PubMed: 12090883]
104.
Satia-Abouta J, Kristal AR, Patterson RE, et al. Dietary supplement use and medical conditions: the VITAL study. Am J Prev Med. 2003;24:43–51. [PubMed: 12554023]
105.
Miller ER III, Pastor-Barriuso R, Dalal D, et al. Meta-analysis: high-dosage vitamin E supplementation may increase all-cause mortality. Ann Intern Med. 2005;142:37–46. [PubMed: 15537682]
106.
Bardia A, Tleyjeh IM, Cerhan JR, et al. Efficacy of antioxidant supplementation in reducing primary cancer incidence and mortality: systematic review and meta-analysis. Mayo Clin Proc. 2008;83:23–34. [PubMed: 18173999]
107.
Bjelakovic G, Nikolova D, Gluud LL, et al. Antioxidant supplements for prevention of mortality in healthy participants and patients with various diseases. Cochrane Database Syst Rev. 2008. CD007176. [PubMed: 18425980]
108.
Lin J, Cook NR, Albert C, et al. Vitamins C and E and beta carotene supplementation and cancer risk: a randomized controlled trial. J Natl Cancer Inst. 2009;101:14–23. [PMC free article: PMC2615459] [PubMed: 19116389]
109.
Bang HO, Dyerberg J, Sinclair HM. The composition of the Eskimo food in north western Greenland. Am J Clin Nutr. 1980;33:2657–61. [PubMed: 7435433]
110.
Dyerberg J, Bang HO, Stoffersen E, et al. Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet. 1978;2:117–9. [PubMed: 78322]

Views

  • PubReader
  • Print View
  • Cite this Page
  • PDF version of this title (1.3M)

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...